Cme Group (CME) Financials & Stock Analysis

Cme Group

NASDAQ: CME · USD

Revenue

USD millions

$1,706.2M

Cme Group Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
Period	Revenue
FY 2009 Q2	$647.8M; Change unavailable vs FY 2009 Q1
FY 2009 Q3	$650.4M; +0.4% vs FY 2009 Q2
FY 2009 Q4	$667.5M; +2.6% vs FY 2009 Q3
FY 2010 Q1	$693.2M; +3.9% vs FY 2009 Q4
FY 2010 Q2	$813.9M; +17.4% vs FY 2010 Q1
FY 2010 Q3	$733.4M; −9.9% vs FY 2010 Q2
FY 2010 Q4	$763.2M; +4.1% vs FY 2010 Q3
FY 2011 Q1	$831.6M; +9.0% vs FY 2010 Q4
FY 2011 Q2	$838.3M; +0.8% vs FY 2011 Q1
FY 2011 Q3	$874.2M; +4.3% vs FY 2011 Q2
FY 2011 Q4	$736.5M; −15.8% vs FY 2011 Q3
FY 2012 Q1	$774.6M; +5.2% vs FY 2011 Q4
FY 2012 Q2	$795.9M; +2.7% vs FY 2012 Q1
FY 2012 Q3	$683.2M; −14.2% vs FY 2012 Q2
FY 2012 Q4	$660.9M; −3.3% vs FY 2012 Q3
FY 2013 Q1	$718.6M; +8.7% vs FY 2012 Q4
FY 2013 Q2	$816.1M; +13.6% vs FY 2013 Q1
FY 2013 Q3	$714.6M; −12.4% vs FY 2013 Q2
FY 2013 Q4	$687M; −3.9% vs FY 2013 Q3
FY 2014 Q1	$777.4M; +13.2% vs FY 2013 Q4
FY 2014 Q2	$731.6M; −5.9% vs FY 2014 Q1
FY 2014 Q3	$762.4M; +4.2% vs FY 2014 Q2
FY 2014 Q4	$841.1M; +10.3% vs FY 2014 Q3
FY 2015 Q1	$842.7M; +0.2% vs FY 2014 Q4
FY 2015 Q2	$820M; −2.7% vs FY 2015 Q1
FY 2015 Q3	$850.3M; +3.7% vs FY 2015 Q2
FY 2015 Q4	$813.8M; −4.3% vs FY 2015 Q3
FY 2016 Q1	$934.2M; +14.8% vs FY 2015 Q4
FY 2016 Q2	$906.4M; −3.0% vs FY 2016 Q1
FY 2016 Q3	$841.7M; −7.1% vs FY 2016 Q2
FY 2016 Q4	$912.9M; +8.5% vs FY 2016 Q3
FY 2017 Q1	$929.3M; +1.8% vs FY 2016 Q4
FY 2017 Q2	$924.6M; −0.5% vs FY 2017 Q1
FY 2017 Q3	$890.8M; −3.7% vs FY 2017 Q2
FY 2017 Q4	$900M; +1.0% vs FY 2017 Q3
FY 2018 Q1	$1,109M; +23.2% vs FY 2017 Q4
FY 2018 Q2	$1,059.6M; −4.5% vs FY 2018 Q1
FY 2018 Q3	$904.2M; −14.7% vs FY 2018 Q2
FY 2018 Q4	$1,236.6M; +36.8% vs FY 2018 Q3
FY 2019 Q1	$1,179.6M; −4.6% vs FY 2018 Q4
FY 2019 Q2	$1,272.7M; +7.9% vs FY 2019 Q1
FY 2019 Q3	$1,277.3M; +0.4% vs FY 2019 Q2
FY 2019 Q4	$1,138.4M; −10.9% vs FY 2019 Q3
FY 2020 Q1	$1,522.1M; +33.7% vs FY 2019 Q4
FY 2020 Q2	$1,182.3M; −22.3% vs FY 2020 Q1
FY 2020 Q3	$1,080.7M; −8.6% vs FY 2020 Q2
FY 2020 Q4	$1,098.5M; +1.6% vs FY 2020 Q3
FY 2021 Q1	$1,253.3M; +14.1% vs FY 2020 Q4
FY 2021 Q2	$1,179.2M; −5.9% vs FY 2021 Q1
FY 2021 Q3	$1,109.9M; −5.9% vs FY 2021 Q2
FY 2021 Q4	$1,147.3M; +3.4% vs FY 2021 Q3
FY 2022 Q1	$1,346.6M; +17.4% vs FY 2021 Q4
FY 2022 Q2	$1,237.2M; −8.1% vs FY 2022 Q1
FY 2022 Q3	$1,227.8M; −0.8% vs FY 2022 Q2
FY 2022 Q4	$1,207.8M; −1.6% vs FY 2022 Q3
FY 2023 Q1	$1,441.6M; +19.4% vs FY 2022 Q4
FY 2023 Q2	$1,360.2M; −5.6% vs FY 2023 Q1
FY 2023 Q3	$1,337.8M; −1.6% vs FY 2023 Q2
FY 2023 Q4	$1,439.3M; +7.6% vs FY 2023 Q3
FY 2024 Q1	$1,487.9M; +3.4% vs FY 2023 Q4
FY 2024 Q2	$1,532.5M; +3.0% vs FY 2024 Q1
FY 2024 Q3	$1,584.4M; +3.4% vs FY 2024 Q2
FY 2024 Q4	$1,525.3M; −3.7% vs FY 2024 Q3
FY 2025 Q1	$1,642.3M; +7.7% vs FY 2024 Q4
FY 2025 Q2	$1,692M; +3.0% vs FY 2025 Q1
FY 2025 Q3	$1,537.6M; −9.1% vs FY 2025 Q2
FY 2025 Q4	$1,648.7M; +7.2% vs FY 2025 Q3
FY 2026 Q1	$1,880.1M; +14.0% vs FY 2025 Q4
FY 2026 Q2	$1,706.2M; −9.2% vs FY 2026 Q1

Free cash flow

USD millions

$923.5M

Cme Group Free cash flow. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
Period	Free cash flow
FY 2009 Q2	$140M; Change unavailable vs FY 2009 Q1
FY 2009 Q3	$265.5M; +89.6% vs FY 2009 Q2
FY 2009 Q4	$300.3M; +13.1% vs FY 2009 Q3
FY 2010 Q1	$329.4M; +9.7% vs FY 2009 Q4
FY 2010 Q2	$265.9M; −19.3% vs FY 2010 Q1
FY 2010 Q3	$270M; +1.5% vs FY 2010 Q2
FY 2010 Q4	$331.1M; +22.6% vs FY 2010 Q3
FY 2011 Q1	$320.7M; −3.1% vs FY 2010 Q4
FY 2011 Q2	$167M; −47.9% vs FY 2011 Q1
FY 2011 Q3	$382.7M; +129.2% vs FY 2011 Q2
FY 2011 Q4	$303.7M; −20.6% vs FY 2011 Q3
FY 2012 Q1	$368.9M; +21.5% vs FY 2011 Q4
FY 2012 Q2	$225.3M; −38.9% vs FY 2012 Q1
FY 2012 Q3	$199.1M; −11.6% vs FY 2012 Q2
FY 2012 Q4	$281.7M; +41.5% vs FY 2012 Q3
FY 2013 Q1	$375.8M; +33.4% vs FY 2012 Q4
FY 2013 Q2	$337.2M; −10.3% vs FY 2013 Q1
FY 2013 Q3	$90.9M; −73.0% vs FY 2013 Q2
FY 2013 Q4	$351M; +286.1% vs FY 2013 Q3
FY 2014 Q1	$346.5M; −1.3% vs FY 2013 Q4
FY 2014 Q2	$130.8M; −62.3% vs FY 2014 Q1
FY 2014 Q3	$207.4M; +58.6% vs FY 2014 Q2
FY 2014 Q4	$466M; +124.7% vs FY 2014 Q3
FY 2015 Q1	$387.5M; −16.8% vs FY 2014 Q4
FY 2015 Q2	$229.5M; −40.8% vs FY 2015 Q1
FY 2015 Q3	$433.9M; +89.1% vs FY 2015 Q2
FY 2015 Q4	$350.2M; −19.3% vs FY 2015 Q3
FY 2016 Q1	$499.5M; +42.6% vs FY 2015 Q4
FY 2016 Q2	$204.1M; −59.1% vs FY 2016 Q1
FY 2016 Q3	$439.1M; +115.1% vs FY 2016 Q2
FY 2016 Q4	$481.5M; +9.7% vs FY 2016 Q3
FY 2017 Q1	$498.7M; +3.6% vs FY 2016 Q4
FY 2017 Q2	$286.7M; −42.5% vs FY 2017 Q1
FY 2017 Q3	$491.8M; +71.5% vs FY 2017 Q2
FY 2017 Q4	$481.3M; −2.1% vs FY 2017 Q3
FY 2018 Q1	$806.8M; +67.6% vs FY 2017 Q4
FY 2018 Q2	$511.4M; −36.6% vs FY 2018 Q1
FY 2018 Q3	$551.3M; +7.8% vs FY 2018 Q2
FY 2018 Q4	$454.6M; −17.5% vs FY 2018 Q3
FY 2019 Q1	$620.1M; +36.4% vs FY 2018 Q4
FY 2019 Q2	$401.2M; −35.3% vs FY 2019 Q1
FY 2019 Q3	$752.6M; +87.6% vs FY 2019 Q2
FY 2019 Q4	$653.3M; −13.2% vs FY 2019 Q3
FY 2020 Q1	$714.3M; +9.3% vs FY 2019 Q4
FY 2020 Q2	$950.4M; +33.1% vs FY 2020 Q1
FY 2020 Q3	$263.1M; −72.3% vs FY 2020 Q2
FY 2020 Q4	$590.3M; +124.4% vs FY 2020 Q3
FY 2021 Q1	$574.2M; −2.7% vs FY 2020 Q4
FY 2021 Q2	$460.1M; −19.9% vs FY 2021 Q1
FY 2021 Q3	$599.9M; +30.4% vs FY 2021 Q2
FY 2021 Q4	$641M; +6.9% vs FY 2021 Q3
FY 2022 Q1	$775.7M; +21.0% vs FY 2021 Q4
FY 2022 Q2	$599.7M; −22.7% vs FY 2022 Q1
FY 2022 Q3	$633.8M; +5.7% vs FY 2022 Q2
FY 2022 Q4	$957.1M; +51.0% vs FY 2022 Q3
FY 2023 Q1	$887.2M; −7.3% vs FY 2022 Q4
FY 2023 Q2	$629.9M; −29.0% vs FY 2023 Q1
FY 2023 Q3	$836.8M; +32.8% vs FY 2023 Q2
FY 2023 Q4	$1,023.5M; +22.3% vs FY 2023 Q3
FY 2024 Q1	$872.9M; −14.7% vs FY 2023 Q4
FY 2024 Q2	$758.7M; −13.1% vs FY 2024 Q1
FY 2024 Q3	$973.2M; +28.3% vs FY 2024 Q2
FY 2024 Q4	$991.7M; +1.9% vs FY 2024 Q3
FY 2025 Q1	$1,102.4M; +11.2% vs FY 2024 Q4
FY 2025 Q2	$1,040.1M; −5.7% vs FY 2025 Q1
FY 2025 Q3	$949.7M; −8.7% vs FY 2025 Q2
FY 2025 Q4	$1,101.4M; +16.0% vs FY 2025 Q3
FY 2026 Q1	$1,238.1M; +12.4% vs FY 2025 Q4
FY 2026 Q2	$923.5M; −25.4% vs FY 2026 Q1

Net margin

61.06%

Cme Group Net margin. Reported fiscal history.
Fiscal period	%
FY 2009 Q2	34.24%
FY 2009 Q3	31.1%
FY 2009 Q4	30.35%
FY 2010 Q1	34.65%
FY 2010 Q2	33.26%
FY 2010 Q3	33.31%
FY 2010 Q4	25.71%
FY 2011 Q1	54.91%
FY 2011 Q2	35.04%
FY 2011 Q3	36.16%
FY 2011 Q4	101.28%
FY 2012 Q1	34.42%
FY 2012 Q2	30.77%
FY 2012 Q3	31.91%
FY 2012 Q4	25.24%
FY 2013 Q1	32.81%
FY 2013 Q2	38.13%
FY 2013 Q3	33.12%
FY 2013 Q4	28.11%
FY 2014 Q1	34.32%
FY 2014 Q2	36.06%
FY 2014 Q3	38.04%
FY 2014 Q4	36.44%
FY 2015 Q1	39.21%
FY 2015 Q2	32.32%
FY 2015 Q3	42.33%
FY 2015 Q4	35.84%
FY 2016 Q1	39.37%
FY 2016 Q2	35.32%
FY 2016 Q3	56.17%
FY 2016 Q4	40.9%
FY 2017 Q1	43.02%
FY 2017 Q2	44.97%
FY 2017 Q3	34.64%
FY 2017 Q4	326.58%
FY 2018 Q1	53.99%
FY 2018 Q2	53.43%
FY 2018 Q3	45.54%
FY 2018 Q4	31.17%
FY 2019 Q1	42.12%
FY 2019 Q2	40.37%
FY 2019 Q3	49.82%
FY 2019 Q4	41.24%
FY 2020 Q1	50.34%
FY 2020 Q2	42.57%
FY 2020 Q3	38.1%
FY 2020 Q4	38.6%
FY 2021 Q1	45.83%
FY 2021 Q2	43.28%
FY 2021 Q3	83.48%
FY 2021 Q4	54.49%
FY 2022 Q1	52.8%
FY 2022 Q2	53.55%
FY 2022 Q3	55.35%
FY 2022 Q4	52.82%
FY 2023 Q1	61.31%
FY 2023 Q2	57.17%
FY 2023 Q3	56.08%
FY 2023 Q4	—
FY 2024 Q1	57.48%
FY 2024 Q2	57.63%
FY 2024 Q3	57.61%
FY 2024 Q4	—
FY 2025 Q1	58.22%
FY 2025 Q2	60.59%
FY 2025 Q3	59.05%
FY 2025 Q4	—
FY 2026 Q1	61.4%
FY 2026 Q2	61.06%

P/E

× · TTM · Daily

22.35×

Cme Group P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date	× · TTM · Daily	Financials through
2011-03-31	21.24×	2010-12-31
2011-04-29	20.83×	2010-12-31
2011-05-31	20.13×	2010-12-31
2011-06-30	20.54×	2010-12-31
2011-07-29	20.37×	2010-12-31
2011-08-31	18.82×	2010-12-31
2011-09-30	17.36×	2010-12-31
2011-10-31	19.41×	2010-12-31
2011-11-30	17.56×	2010-12-31
2011-12-30	17.16×	2010-12-31
2012-01-31	16.87×	2010-12-31
2012-02-29	20.39×	2010-12-31
2012-03-30	20.38×	2010-12-31
2012-04-30	18.72×	2010-12-31
2012-05-31	13.6×	2011-09-30
2012-06-29	14.16×	2011-09-30
2012-07-31	13.76×	2011-09-30
2012-08-31	14.49×	2011-09-30
2012-09-28	15.12×	2011-09-30
2012-10-31	14.77×	2011-09-30
2012-11-30	10.12×	2011-12-31
2012-12-31	9.28×	2011-12-31
2013-01-31	10.59×	2011-12-31
2013-02-28	10.92×	2011-12-31
2013-03-28	11.24×	2011-12-31
2013-04-30	11.14×	2011-12-31
2013-05-31	12.43×	2011-12-31
2013-06-28	13.9×	2011-12-31
2013-07-31	13.56×	2011-12-31
2013-08-30	13.02×	2011-12-31
2013-09-30	13.52×	2011-12-31
2013-10-31	13.58×	2011-12-31
2013-11-29	15×	2011-12-31
2013-12-31	14.36×	2011-12-31
2014-01-31	13.69×	2011-12-31
2014-02-28	13.51×	2011-12-31
2014-03-31	16.68×	2012-09-30
2014-04-30	15.86×	2012-09-30
2014-05-30	23.98×	2014-03-31
2014-06-30	23.63×	2014-03-31
2014-07-31	24.63×	2014-03-31
2014-08-29	26.77×	2014-06-30
2014-09-30	27.96×	2014-06-30
2014-10-31	29.3×	2014-06-30
2014-11-28	28.07×	2014-09-30
2014-12-31	29.4×	2014-09-30
2015-01-30	28.29×	2014-09-30
2015-02-27	28.66×	2014-12-31
2015-03-31	28.3×	2014-12-31
2015-04-30	27.16×	2014-12-31
2015-05-29	26.69×	2015-03-31
2015-06-30	26.37×	2015-03-31
2015-07-31	27.22×	2015-03-31
2015-08-31	26.77×	2015-06-30
2015-09-30	26.28×	2015-06-30
2015-10-30	26.77×	2015-06-30
2015-11-30	26.17×	2015-09-30
2015-12-31	24.28×	2015-09-30
2016-01-29	24.08×	2015-09-30
2016-02-29	24.8×	2015-12-31
2016-03-31	26.05×	2015-12-31
2016-04-29	24.92×	2015-12-31
2016-05-31	25.8×	2016-03-31
2016-06-30	25.67×	2016-03-31
2016-07-29	26.95×	2016-03-31
2016-08-31	28.56×	2016-03-31
2016-09-30	27.55×	2016-03-31
2016-10-31	26.38×	2016-03-31
2016-11-30	29.76×	2016-03-31
2016-12-30	30.4×	2016-03-31
2017-01-31	31.91×	2016-03-31
2017-02-28	26.87×	2016-12-31
2017-03-31	26.28×	2016-12-31
2017-04-28	25.7×	2016-12-31
2017-05-31	25.95×	2016-12-31
2017-06-30	27.7×	2016-12-31
2017-07-31	27.12×	2016-12-31
2017-08-31	27.83×	2016-12-31
2017-09-29	30.01×	2016-12-31
2017-10-31	30.34×	2016-12-31
2017-11-30	33.08×	2016-12-31
2017-12-29	32.31×	2016-12-31
2018-01-31	33.95×	2016-12-31
2018-02-28	36.76×	2016-12-31
2018-03-29	35.11×	2017-03-31
2018-04-30	34.23×	2017-03-31
2018-05-31	35.36×	2017-03-31
2018-06-29	35.58×	2017-03-31
2018-07-31	34.54×	2017-03-31
2018-08-31	37.93×	2017-03-31
2018-09-28	36.95×	2017-03-31
2018-10-31	39.78×	2017-03-31
2018-11-30	41.26×	2017-03-31
2018-12-31	40.83×	2017-03-31
2019-01-31	39.57×	2017-03-31
2019-02-28	39.49×	2017-03-31
2019-03-29	29.54×	2018-12-31
2019-04-30	32.11×	2018-12-31
2019-05-31	34.48×	2018-12-31
2019-06-28	34.83×	2018-12-31
2019-07-31	34.89×	2018-12-31
2019-08-30	38.99×	2018-12-31
2019-09-30	37.93×	2018-12-31
2019-10-31	36.92×	2018-12-31
2019-11-29	36.38×	2018-12-31
2019-12-31	36.02×	2018-12-31
2020-01-31	38.96×	2018-12-31
2020-02-28	35.68×	2018-12-31
2020-03-31	29.28×	2019-12-31
2020-04-30	30.17×	2019-12-31
2020-05-29	30.92×	2019-12-31
2020-06-30	27.52×	2019-12-31
2020-07-31	28.14×	2019-12-31
2020-08-31	29.78×	2019-12-31
2020-09-30	28.33×	2019-12-31
2020-10-30	25.52×	2019-12-31
2020-11-30	29.18×	2020-09-30
2020-12-31	30.35×	2020-09-30
2021-01-29	30.3×	2020-09-30
2021-02-26	33.3×	2020-09-30
2021-03-31	34.05×	2020-09-30
2021-04-30	33.68×	2020-09-30
2021-05-28	41.02×	2021-03-31
2021-06-30	39.88×	2021-03-31
2021-07-30	39.78×	2021-03-31
2021-08-31	37.7×	2021-06-30
2021-09-30	36.14×	2021-06-30
2021-10-29	41.22×	2021-06-30
2021-11-30	32.51×	2021-09-30
2021-12-31	33.68×	2021-09-30
2022-01-31	33.83×	2021-09-30
2022-02-28	32.45×	2021-12-31
2022-03-31	32.63×	2021-12-31
2022-04-29	30.09×	2021-12-31
2022-05-31	27.28×	2021-12-31
2022-06-30	28.08×	2021-12-31
2022-07-29	27.37×	2021-12-31
2022-08-31	26.84×	2021-12-31
2022-09-30	24.3×	2021-12-31
2022-10-31	23.77×	2021-12-31
2022-11-30	24.08×	2022-09-30
2022-12-30	22.95×	2022-09-30
2023-01-31	24.11×	2022-09-30
2023-02-28	25.29×	2022-09-30
2023-03-31	26.13×	2022-09-30
2023-04-28	25.35×	2022-09-30
2023-05-31	22.71×	2023-03-31
2023-06-30	23.54×	2023-03-31
2023-07-31	25.28×	2023-03-31
2023-08-31	24.77×	2023-06-30
2023-09-29	24.46×	2023-06-30
2023-10-31	26.08×	2023-06-30
2023-11-30	26.08×	2023-09-30
2023-12-29	25.15×	2023-09-30
2024-01-31	24.58×	2023-09-30
2024-02-29	24.88×	2023-12-31
2024-03-28	24.31×	2023-12-31
2024-04-30	23.67×	2023-12-31
2024-05-31	23.13×	2024-03-31
2024-06-28	22.41×	2024-03-31
2024-07-31	22.08×	2024-03-31
2024-08-30	23.8×	2024-06-30
2024-09-30	24.35×	2024-06-30
2024-10-31	24.87×	2024-06-30
2024-11-29	25.04×	2024-09-30
2024-12-31	24.43×	2024-09-30
2025-01-31	24.88×	2024-09-30
2025-02-28	26.7×	2024-09-30
2025-03-31	27.91×	2024-09-30
2025-04-30	29.15×	2024-09-30
2025-05-30	29.07×	2025-03-31
2025-06-30	27.72×	2025-03-31
2025-07-31	26.95×	2025-06-30
2025-08-29	25.81×	2025-06-30
2025-09-30	26.16×	2025-06-30
2025-10-31	25.75×	2025-09-30
2025-11-28	27.29×	2025-09-30
2025-12-31	26.48×	2025-09-30
2026-01-30	28.03×	2025-09-30
2026-02-27	28.62×	2025-12-31
2026-03-31	26.46×	2025-12-31
2026-04-30	24.63×	2026-03-31
2026-05-29	23.41×	2026-03-31
2026-06-30	18.9×	2026-03-31
2026-07-31	22.63×	2026-06-30
2026-08-31	24.13×	2026-06-30
2026-09-25	22.35×	2026-06-30

ROIC

% · Annual / TTM

—

Reported borrowing balances are unavailable in the extracted statements for this period.

Cme Group ROIC. Reported fiscal history.
Fiscal period	% · Annual / TTM
FY 2009 Q2	—
FY 2009 Q3	—
FY 2009 Q4	—
FY 2010 Q1	—
FY 2010 Q2	—
FY 2010 Q3	—
FY 2010 Q4	—
FY 2011 Q1	—
FY 2011 Q2	—
FY 2011 Q3	—
FY 2011 Q4	—
FY 2012 Q1	—
FY 2012 Q2	—
FY 2012 Q3	—
FY 2012 Q4	—
FY 2013 Q1	—
FY 2013 Q2	—
FY 2013 Q3	—
FY 2013 Q4	—
FY 2014 Q1	—
FY 2014 Q2	—
FY 2014 Q3	—
FY 2014 Q4	—
FY 2015 Q1	—
FY 2015 Q2	—
FY 2015 Q3	—
FY 2015 Q4	—
FY 2016 Q1	—
FY 2016 Q2	—
FY 2016 Q3	—
FY 2016 Q4	—
FY 2017 Q1	—
FY 2017 Q2	—
FY 2017 Q3	—
FY 2017 Q4	—
FY 2018 Q1	—
FY 2018 Q2	—
FY 2018 Q3	—
FY 2018 Q4	—
FY 2019 Q1	—
FY 2019 Q2	—
FY 2019 Q3	—
FY 2019 Q4	—
FY 2020 Q1	—
FY 2020 Q2	—
FY 2020 Q3	—
FY 2020 Q4	—
FY 2021 Q1	—
FY 2021 Q2	—
FY 2021 Q3	—
FY 2021 Q4	—
FY 2022 Q1	—
FY 2022 Q2	—
FY 2022 Q3	—
FY 2022 Q4	—
FY 2023 Q1	—
FY 2023 Q2	—
FY 2023 Q3	—
FY 2023 Q4	—
FY 2024 Q1	—
FY 2024 Q2	—
FY 2024 Q3	—
FY 2024 Q4	—
FY 2025 Q1	—
FY 2025 Q2	—
FY 2025 Q3	—
FY 2025 Q4	—
FY 2026 Q1	—
FY 2026 Q2	—

Capital allocation

% of tracked cash uses

$491.7M

Cme Group capital allocation. Quarterly values. Missing values are unavailable.
Period	Capex	Acquisitions	Buybacks	Dividends	Debt repayments	Tracked uses
FY 2009 Q2	36.42% · $43.7M	Unavailable	0% · $0M	63.58% · $76.3M	Unavailable	100% · $120M
FY 2009 Q3	30.73% · $33.9M	0% · $0M	0% · $0M	69.27% · $76.4M	Unavailable	100% · $110.3M
FY 2009 Q4	37.01% · $45M	0% · $0M	0% · $0M	62.99% · $76.6M	Unavailable	100% · $121.6M
FY 2010 Q1	6.85% · $26.3M	Unavailable	73.39% · $281.8M	19.77% · $75.9M	Unavailable	100% · $384M
FY 2010 Q2	23.4% · $27.5M	Unavailable	12.26% · $14.4M	64.34% · $75.6M	Unavailable	100% · $117.5M
FY 2010 Q3	10.98% · $43.9M	Unavailable	69.8% · $279M	19.21% · $76.8M	Unavailable	100% · $399.7M
FY 2010 Q4	44.69% · $62.3M	Unavailable	0.07% · $0.1M	55.24% · $77M	Unavailable	100% · $139.4M
FY 2011 Q1	30.67% · $41.4M	Unavailable	Unavailable	69.33% · $93.6M	Unavailable	100% · $135M
FY 2011 Q2	33.36% · $47M	Unavailable	Unavailable	66.64% · $93.9M	Unavailable	100% · $140.9M
FY 2011 Q3	14.18% · $41M	Unavailable	53.63% · $155.1M	32.19% · $93.1M	Unavailable	100% · $289.2M
FY 2011 Q4	31.7% · $42.8M	Unavailable	0% · $0M	68.3% · $92.2M	Unavailable	100% · $135M
FY 2012 Q1	7.15% · $26.7M	Unavailable	Unavailable	92.85% · $346.5M	Unavailable	100% · $373.2M
FY 2012 Q2	19.99% · $36.9M	Unavailable	Unavailable	80.01% · $147.7M	Unavailable	100% · $184.6M
FY 2012 Q3	21.17% · $40.3M	Unavailable	0% · $0M	78.83% · $150.1M	Unavailable	100% · $190.4M
FY 2012 Q4	6.13% · $37.9M	Unavailable	0% · $0M	93.87% · $580M	Unavailable	100% · $617.9M
FY 2013 Q1	11.91% · $20.2M	Unavailable	Unavailable	88.09% · $149.4M	0% · $0M	100% · $169.6M
FY 2013 Q2	19.14% · $35.6M	Unavailable	Unavailable	80.86% · $150.4M	0% · $0M	100% · $186M
FY 2013 Q3	4.14% · $38.9M	Unavailable	Unavailable	15.96% · $149.8M	79.9% · $750M	100% · $938.7M
FY 2013 Q4	17.13% · $30.9M	Unavailable	Unavailable	82.87% · $149.5M	Unavailable	100% · $180.4M
FY 2014 Q1	2.01% · $36.5M	Unavailable	Unavailable	56.58% · $1,025M	41.4% · $750M	100% · $1,811.5M
FY 2014 Q2	20.66% · $40.9M	Unavailable	Unavailable	79.34% · $157.1M	0% · $0M	100% · $198M
FY 2014 Q3	14.57% · $26.8M	Unavailable	Unavailable	85.43% · $157.1M	0% · $0M	100% · $183.9M
FY 2014 Q4	18.8% · $36.5M	Unavailable	Unavailable	81.2% · $157.6M	Unavailable	100% · $194.1M
FY 2015 Q1	3.61% · $31.4M	Unavailable	Unavailable	96.39% · $838.8M	0% · $0M	100% · $870.2M
FY 2015 Q2	3.37% · $29.3M	Unavailable	Unavailable	19.29% · $167.9M	77.34% · $673M	100% · $870.2M
FY 2015 Q3	14.96% · $29.6M	Unavailable	Unavailable	85.04% · $168.2M	0% · $0M	100% · $197.8M
FY 2015 Q4	12.42% · $23.9M	Unavailable	Unavailable	87.58% · $168.5M	Unavailable	100% · $192.4M
FY 2016 Q1	1.68% · $20.2M	Unavailable	Unavailable	98.32% · $1,179.3M	Unavailable	100% · $1,199.5M
FY 2016 Q2	8.75% · $19.4M	Unavailable	Unavailable	91.25% · $202.4M	Unavailable	100% · $221.8M
FY 2016 Q3	10.31% · $23.3M	Unavailable	Unavailable	89.69% · $202.6M	0% · $0M	100% · $225.9M
FY 2016 Q4	12.47% · $28.9M	Unavailable	Unavailable	87.53% · $202.9M	Unavailable	100% · $231.8M
FY 2017 Q1	1.49% · $20M	Unavailable	Unavailable	98.51% · $1,322.6M	Unavailable	100% · $1,342.6M
FY 2017 Q2	7.3% · $17.6M	Unavailable	Unavailable	92.7% · $223.5M	Unavailable	100% · $241.1M
FY 2017 Q3	6.45% · $15.4M	Unavailable	Unavailable	93.55% · $223.5M	Unavailable	100% · $238.9M
FY 2017 Q4	11.43% · $28.9M	Unavailable	Unavailable	88.57% · $223.9M	Unavailable	100% · $252.8M
FY 2018 Q1	1.26% · $18.2M	Unavailable	Unavailable	98.74% · $1,424.8M	0% · $0M	100% · $1,443M
FY 2018 Q2	4.58% · $11.4M	Unavailable	Unavailable	95.42% · $237.7M	0% · $0M	100% · $249.1M
FY 2018 Q3	11.64% · $31.3M	Unavailable	Unavailable	88.36% · $237.6M	0% · $0M	100% · $268.9M
FY 2018 Q4	18.26% · $55.8M	Unavailable	Unavailable	81.74% · $249.8M	Unavailable	100% · $305.6M
FY 2019 Q1	3.25% · $49.1M	Unavailable	Unavailable	59.06% · $892.1M	37.69% · $569.2M	100% · $1,510.4M
FY 2019 Q2	21.3% · $72.5M	Unavailable	Unavailable	78.7% · $267.8M	0% · $0M	100% · $340.3M
FY 2019 Q3	17.7% · $57.6M	Unavailable	Unavailable	82.3% · $267.9M	0% · $0M	100% · $325.5M
FY 2019 Q4	19.85% · $66.4M	Unavailable	Unavailable	80.15% · $268.1M	Unavailable	100% · $334.5M
FY 2020 Q1	3.45% · $42.8M	Unavailable	Unavailable	96.55% · $1,197.6M	0% · $0M	100% · $1,240.4M
FY 2020 Q2	10.69% · $36.4M	Unavailable	Unavailable	89.31% · $304M	0% · $0M	100% · $340.4M
FY 2020 Q3	13.71% · $48.3M	Unavailable	Unavailable	86.29% · $304.1M	0% · $0M	100% · $352.4M
FY 2020 Q4	18.7% · $70M	Unavailable	Unavailable	81.3% · $304.3M	Unavailable	100% · $374.3M
FY 2021 Q1	2.29% · $28.5M	Unavailable	Unavailable	97.71% · $1,217.5M	0% · $0M	100% · $1,246M
FY 2021 Q2	10.96% · $39.7M	Unavailable	Unavailable	89.04% · $322.5M	0% · $0M	100% · $362.2M
FY 2021 Q3	8.95% · $31.7M	Unavailable	Unavailable	91.05% · $322.5M	0% · $0M	100% · $354.2M
FY 2021 Q4	7.71% · $27.3M	Unavailable	Unavailable	92.29% · $326.8M	Unavailable	100% · $354.1M
FY 2022 Q1	1.01% · $23.4M	Unavailable	Unavailable	66.44% · $1,543.5M	32.55% · $756.1M	100% · $2,323M
FY 2022 Q2	4.69% · $17.9M	Unavailable	Unavailable	95.28% · $363.3M	0.03% · $0.1M	100% · $381.3M
FY 2022 Q3	6.2% · $24M	Unavailable	Unavailable	93.8% · $363.2M	0% · $0M	100% · $387.2M
FY 2022 Q4	6.29% · $24.4M	Unavailable	Unavailable	93.71% · $363.5M	Unavailable	100% · $387.9M
FY 2023 Q1	0.74% · $15.2M	Unavailable	Unavailable	99.26% · $2,035.6M	0% · $0M	100% · $2,050.8M
FY 2023 Q2	4.69% · $20.5M	Unavailable	Unavailable	91.55% · $399.8M	3.76% · $16.4M	100% · $436.7M
FY 2023 Q3	4.74% · $19.9M	Unavailable	Unavailable	95.26% · $400M	0% · $0M	100% · $419.9M
FY 2023 Q4	4.94% · $20.8M	Unavailable	Unavailable	95.06% · $400.1M	Unavailable	100% · $420.9M
FY 2024 Q1	0.84% · $19.8M	Unavailable	Unavailable	99.16% · $2,328.4M	0% · $0M	100% · $2,348.2M
FY 2024 Q2	4.17% · $18.2M	Unavailable	Unavailable	95.83% · $418.5M	0% · $0M	100% · $436.7M
FY 2024 Q3	6.65% · $29.8M	Unavailable	Unavailable	93.35% · $418.5M	0% · $0M	100% · $448.3M
FY 2024 Q4	5.89% · $26.2M	Unavailable	Unavailable	94.11% · $418.8M	Unavailable	100% · $445M
FY 2025 Q1	0.43% · $14.2M	Unavailable	Unavailable	77.06% · $2,567.4M	22.51% · $750M	100% · $3,331.6M
FY 2025 Q2	3.88% · $18.4M	Unavailable	Unavailable	96.12% · $455.3M	0% · $0M	100% · $473.7M
FY 2025 Q3	3.88% · $18.4M	Unavailable	Unavailable	96.12% · $455.3M	0% · $0M	100% · $473.7M
FY 2025 Q4	6.67% · $32.5M	Unavailable	Unavailable	93.33% · $455M	Unavailable	100% · $487.5M
FY 2026 Q1	0.8% · $21.8M	Unavailable	Unavailable	99.2% · $2,697.6M	0% · $0M	100% · $2,719.4M
FY 2026 Q2	4.8% · $23.6M	Unavailable	Unavailable	95.2% · $468.1M	0% · $0M	100% · $491.7M

Sources and calculations

Company filings · USD · Last checked 2026-10-18. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for Cme Group.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

SBC deduction is an optional economic-cost scenario for FCF-based metrics. Missing SBC never becomes zero.

Revenue: Reported revenue from company filings.
Free cash flow: Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Net margin: Reported net income / revenue × 100.
P/E: Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROIC: NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
Capital allocation: Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.

Reported revenue and sources

Cme Group financials